Parkinson's DiseaseNCT00217321
Parkinson's Disease Registry of the Muhammad Ali Parkinson Center
An observational study of Parkinson's Disease, run by Muhammad Ali Parkinson Research Center at 1 site in United States.
Trial summary
The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Parkinson's Disease
- How many people
- 20,000 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2003to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Participants must be over 18 years old, have idiopathic Parkinson's disease diagnosed by a physician.
Who may be able to join
- Clinical diagnosis of Parkinson's disease
Who cannot join
- No clinical diagnosis of Parkinson's disease
Trial locations and contacts
1 site in 1 country.
United States1 site
Muhammad Ali Parkinson Research Center
Phoenix, Arizona, 85013
About this study
Official title: Parkinson's Disease Registry
The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.
Objectives include:
- Assess current treatment approaches and develop best-practice guidelines
- Track the functional abilities, access to healthcare and cost of illness of people with PD over time
- Drive the development of innovative research projects
- Accelerate the process of informing patients of research projects for which they may be eligible
Read the detailed description
What do you need to know?
- Any individual diagnosed with PD is eligible to enroll.
- Participation in the registry is voluntary, confidential and free of charge.
- Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter.
- Participants will need to complete an updated questionnaire every six months.
- Participants may also be asked to complete additional surveys for PD research projects.
- Any data provided will be used in scientific publications in summary form only.
- Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.
- Conditions
- Parkinson's Disease
- Keywords
- Parkinson's disease, Parkinson disease, Registry, quality of life, database
- Medical subject headings
- Parkinson Disease
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Sep 2005 (estimated)
- Study startNov 2003
- Study completionDec 2015 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson's DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Prospective
- Enrolment
- 20,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Muhammad Ali Parkinson Research Center
- Sponsor type
- University, hospital or other
- Collaborators
- Barrow Neurological Foundation
- Investigators
- Abraham Lieberman, MD, Principal investigator, MAPC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00217321
- Sponsor's protocol ID
- 03BN117
- Status last verified
- Sep 2006
- First submitted
- 15 Sep 2005
- Last updated
- 21 Jul 2010
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Parkinson's Disease Registry
- ClinicalTrials.gov ID
- NCT00217321
- Acronym / sponsor ID
- 03BN117
- Conditions
- Parkinson's Disease
- Keywords
- Parkinson's disease, Parkinson disease, Registry, quality of life, database
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 20,000 participants (estimated)
- Lead sponsor
- Muhammad Ali Parkinson Research CenterUniversity, hospital or other
- Collaborators
- Barrow Neurological Foundation
- Study start
- Nov 2003
- Study completion
- Dec 2015 (estimated)
- First posted
- 22 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the Parkinson's disease Registry is to develop a national and international database of persons with Parkinson's disease (PD). The Registry will be used to facilitate the development of new therapies and healthcare services to improve the quality of life for people with PD. It will also be a means for investigators in the field of PD to quickly identify and notify subjects about other research studies for which they are eligible.
Objectives include:
- Assess current treatment approaches and develop best-practice guidelines
- Track the functional abilities, access to healthcare and cost of illness of people with PD over time
- Drive the development of innovative research projects
- Accelerate the process of informing patients of research projects for which they may be eligible
Detailed description
What do you need to know?
- Any individual diagnosed with PD is eligible to enroll.
- Participation in the registry is voluntary, confidential and free of charge.
- Eligible participants will be notified about opportunities to participate in clinical trials, though they are under no obligation to enter.
- Participants will need to complete an updated questionnaire every six months.
- Participants may also be asked to complete additional surveys for PD research projects.
- Any data provided will be used in scientific publications in summary form only.
- Participant names will not be released to anyone outside the Parkinson's disease Registry management team without written authorization, nor will names be sold for advertising or fund-raising purposes.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Participants must be over 18 years old, have idiopathic Parkinson's disease diagnosed by a physician.
Key inclusion criteria (1 listed)
- Clinical diagnosis of Parkinson's disease
Key exclusion criteria (1 listed)
- No clinical diagnosis of Parkinson's disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2010.
Related trials for Parkinson's Disease
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Abraham Lieberman, MD principal investigator
MAPC
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson's Disease, run by Muhammad Ali Parkinson Research Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2010.